Division of Clinical Science, St George's University of London, London, UK.
Respir Med. 2011 Jan;105(1):57-66. doi: 10.1016/j.rmed.2010.09.004. Epub 2010 Oct 6.
Pan-European data on health-related quality of life (HRQL) in chronic obstructive pulmonary disease (COPD) are lacking. This cross-sectional epidemiological study evaluated health status in 1817 COPD patients from an 'all-comers' primary care population in seven European countries (87% stable disease; 13% with current exacerbation) using: St George's Respiratory Questionnaire-COPD specific (SGRQ-C), the short form health survey (SF-12) and the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue scale. Mean total score for SGRQ was 44.7 ± 19.4 showing marked impairment of HRQL. Scores differed little between countries (range 39.2-50.1). Impairment was associated with the severity of airway obstruction, but within each GOLD stage the variation (SD) was wide [Stage I: 38.5 ± 19.3 (n = 223); Stage II: 40.4 ± 18.1 (n = 868); Stage III: 50.2 ± 18.6 (n = 551); Stage IV: 58.6 ± 17.7 (n = 144)]. Patients suffering an exacerbation had a worse SGRQ score (54.9 ± 19.3) than those with stable disease (43.3 ± 19.0). The presence of ≥3 co-morbidities (CM) was also associated with a significantly worse score (49.9 ± 19.1) vs. 1-2 CM (42.1 ± 19.1) or no CM (42.3 ± 18.6). Findings with the SF-12 and FACIT-F results were consistent with those from the SGRQ-C. This large observational primary care study shows that health status is significantly impaired in COPD patients of all severities, even in those with mild airway obstruction. Within each GOLD stage of severity there is considerable heterogeneity in HRQL impairment among patients. (Study number: 111749).
泛欧地区关于慢性阻塞性肺疾病(COPD)患者健康相关生活质量(HRQL)的数据尚缺乏。本项在七个欧洲国家开展的以初级保健人群为基础的、包含所有 COPD 患者的横断面流行病学研究,使用圣乔治呼吸问卷-COPD 专用量表(SGRQ-C)、健康调查简表(SF-12)和慢性疾病治疗功能评估-疲劳量表(FACIT-Fatigue)评估了 1817 例 COPD 患者的健康状况(87%患者病情稳定,13%患者当前处于加重期)。SGRQ-C 总分均值为 44.7±19.4,表明 HRQL 显著受损。各国家间评分差异较小(范围 39.2-50.1)。损害与气道阻塞严重程度相关,但在每个 GOLD 分期内变异(SD)较大[GOLD 分期 I:38.5±19.3(n=223);GOLD 分期 II:40.4±18.1(n=868);GOLD 分期 III:50.2±18.6(n=551);GOLD 分期 IV:58.6±17.7(n=144)]。处于加重期的患者 SGRQ-C 评分(54.9±19.3)较病情稳定的患者(43.3±19.0)更差。≥3 种合并症(CM)的存在也与评分显著恶化相关(49.9±19.1),与 1-2 种 CM(42.1±19.1)或无 CM(42.3±18.6)相比更差。SGRQ-C 结果与 SF-12 和 FACIT-F 的结果一致。这项大规模的初级保健观察性研究表明,所有严重程度的 COPD 患者的健康状况均显著受损,即使是气道阻塞轻度患者也是如此。在每个 GOLD 严重程度分期内,患者的 HRQL 受损程度存在较大的异质性。(研究编号:111749)。